The content of this website does not constitute an offer by any representative of The Green Fund to buy or sell any financial products or services. Market data is provided and copyrighted by Thomson Reuters and Morningstar. The Company offers industrial hemp and medicinal cannabis based dietary supplements and skin care products. The Green Fund disclaims all liability and responsibility for any direct or indirect loss, or damage, which may be incurred by any recipient through any information, omission, error, or inaccuracy contained within any report or recommendation. Elixinol Global (ASX:EXL; OTC:ELLXF) is a global leader in the hemp derived CBD industry, with operations spanning the Americas, Europe and Australia. Accordingly, reliance should not be placed solely on the content of this website, including any reports or recommendations, as the basis for making an investment, financial or other decision. Please choose another, Invalid password: must not contain more than 3 consecutive identical characters, Invalid password: must not contain more than 3 consecutive sequential characters, The password cannot contain the user name, given name, or family name. Any opinions expressed are subject to change without notice and may not be updated by The Green Fund. Market data is provided and copyrighted by Thomson Reuters and Morningstar. You should consult a professional adviser to help you form your own opinion of the information and on whether the information is suitable for your individual objectives and needs as an investor. Elixinol Global, which operates in the industrial hemp, dietary supplements and emerging medicinal cannabis sector, comprises three separate companies. Where necessary, you should obtain a Product Disclosure Statement relating to the product and consider it before making any decision about whether to acquire the product. ASX:EXL - Investor presentation, announcements, cashflow waterfall chart, news, capital raise history, & sector peers. With revenues of $12.5 million in the first 6 months of 2018 (up 119%), and a growing relationship with Kelsey AG in Colorado, this business should see significant growth in 2019 and is in our opinion, the only part of the company offering real value to investors right now. A snapshot of the company you cannot get anywhere else Any financial product advice provided in this website is general in nature. dashboard. Level 36 1 Macquarie Place, Sydney, NSW 2000, Australia. How and when are company announcements published on www.asx.com.au? Elixinol Global, which operates in the industrial hemp, dietary supplements and emerging medicinal cannabis sector, comprises three separate companies. An email containing a verification link has been sent to {{verificationEmail}}. You might already have an ASX account with another platform. Elixinol US is the main business unit. The Green Fund is Asia Pacific's preeminent media house, positioned at the forefront of the global cannabis industry. Click for restrictions. Please log in with your existing credentials, My Market data is provided and copyrighted by Thomson Reuters and Morningstar. Disclaimer: Past performance is not an indicator of future performance. Further improvements to pagination, filtering, and including year on announcements are coming. The access to and use of information made available on the ASX website, including Market Announcements, is subject to the terms of use. Historical market announcements can be found here. The Green Fund and / or its representatives may also transact in those securities mentioned in the report, in a manner not consistent with recommendations made in the report. * Edited text summaries are available from 1 January 1998 to 30 June 2003 Other companies that have used the code 'EXL' profile, My Elixinol Global (ASX:EXL…

A great performer in 2018, we continue to believe that Elixinol has huge upside, and with the passing of the Farm Bill, and a booming CBD-wellness industry in play, are very well placed to grow their US market share. Market data is provided and copyrighted by Thomson Reuters and Morningstar. The Green Fund believes the information contained in this website is correct. The ASX Group's activities span primary and secondary market services, including capital formation and hedging, trading and price discovery (Australian Securities Exchange) central counter party risk transfer (ASX Clearing Corporation); and securities settlement for both the equities and fixed income markets (ASX Settlement Corporation). Important information about market announcements, Invalid password: this word has been flagged as unsuitable for use as a secure password. The information provided in any report and on which it is based may include projections and / or estimates which constitute forward-looking statements. Committed to driving the industry forward, we spotlight the sector from all angles, explore the companies and the players making headlines, and cover some of the biggest cannabis companies in the world. Elixinol US is the main business unit.

All rights reserved. Show Less. All information, opinions, conclusions, estimates, reports or recommendations provided are included with due care to its accuracy; however, no representation or warranty is made as to their accuracy, completeness, or reliability. profile, My Index data is provided © S&P Dow Jones Indices LLC 2020. And finally, there is Elixinol Australia, a late-stage medicinal marijuana applicant, that will be looking to produce premium medicinal marijuana for the emerging Australian medicinal market.

Elixinol Global serves customers worldwide. Useful Information. The company manufactures and distributes hemp-based dietary and skincare products to the US market and exports to another 40 countries globally (including the first-ever CBD-based product to Japan in mid-2018). Any recommendations or opinions stated in a report are done so based on assumptions made by The Green Fund. Become a Patron below and support us in covering the latest marijuana news! dashboard, The access to and use of information made available on the ASX website, including Market Announcements, is subject to the. The Green Fund and / or its associates may hold interests in the entities mentioned in any posted report or recommendation. Recipients should not act on any report or recommendation issued by The Green Fund without first consulting a professional advisor in order to ascertain whether the recommendation (if any) is appropriate, having regard to their investment objectives, financial situation and particular needs. Hemp Foods Australia sells hemp foods and seeds via both a retail network and wholesale channels. The Green Fund, or its representatives, may have relationships with the companies mentioned in posted reports - for example, acting as corporate advisor, dealer, broker, or holder of principal positions. Any forward looking statements are subject to uncertainties and risks that may mean those forecasts made by The Green Fund are materially different to actual events. Invalid password: this word has been flagged as unsuitable for use as a secure password. Read More. Elixinol Global Limited (EXL) manufactures and distributes pharmaceutical products. The other two companies both operate out of Australia. The views expressed in any report or recommendation are those of the analyst writing the report and no part of the compensation received by the analyst is directly related to the inclusion of specific recommendations or opinions. An email containing a verification link has been sent to {{verificationEmail}}. These expressed beliefs of future performance, events, results, or returns may not eventuate and as such no guarantee of these future scenarios is given or implied by The Green Fund.

Find the latest ELIXINOL FPO (EXL.AX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Please log in with your existing credentials, My All rights reserved. Discover expert commentary on Elixinol Global Ltd. EXL:ASX; ELLXF:OTCQX. Is Elixinol Global (ASX:EXL) a buy? Our mission is to make a positive contribution to people's health & wellbeing and the planet through the power of hemp products. Health and wellness company Elixinol Global (ASX:EXL) is on track to post a 10 to 15 per cent growth in revenue over the September quarter. Content on this website does not take into account the objectives, financial situation or needs of any person, or purport to be comprehensive or constitute investment advice and should not be relied upon as such. Receive EXL News and Ratings via Email Sign-up to receive the latest news and ratings for EXL and its competitors with MarketBeat's FREE daily newsletter. You might already have an ASX account with another platform. Please choose another, Invalid password: must not contain more than 3 consecutive identical characters, Invalid password: must not contain more than 3 consecutive sequential characters, The password cannot contain the user name, given name, or family name. Index data is provided © S&P Dow Jones Indices LLC 2020.